/주식/CLLS
CLLS

CLLS

USD

Cellectis S.A. American Depositary Shares

$3.580-0.010 (-0.279%)

실시간 가격

Healthcare
생명공학
프랑스

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$3.590

고가

$3.710

저가

$3.480

거래량

0.00M

기업 기본 정보

시가총액

368.0M

산업

생명공학

국가

France

거래 통계

평균 거래량

0.13M

거래소

NGM

통화

USD

52주 범위

저가 $1.1현재가 $3.580고가 $5.48

관련 뉴스

GlobeNewswire

Cellectis to Present a Development Update for eti-cel at ASH 2025

Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHLPreclinical data demonstrated that combining eti-cel with

더 보기
Cellectis to Present a Development Update for eti-cel at ASH 2025
GlobeNewswire

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies,

더 보기
Cellectis to Report Third Quarter Financial Results on November 7, 2025